Argatroban, 99%

Name: Argatroban, 99% | 74863-84-6
Brand: J&K Chemical
SKU: JK910014_25_MG
Price: 131.5 USD
Availability: InStock

Cat. No JK910014_25_MG

Vendor: J&K Chemical

Product Information

Product Name

Argatroban, 99%

Brand Name

J&K

Product Number

910014

CAS

74863-84-6

Molecular Formula

C23H36N6O5S

Molecular Weight

508.63

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

92722

IUPAC Name

(2R,4R)-1-(2S)-5-(diaminomethylideneamino)-2-(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylaminopentanoyl-4-methylpiperidine-2-carboxylic acid

InChI Key

KXNPVXPOPUZYGB-IOVMHBDKSA-N

SMILES

CC@@H1CCN(C@H(C1)C(=O)O)C(=O)C@H(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C

Safety Information

Storage Condition

Store at 2-8℃

References Data Source From Pubchem

[Development of an infusion regimen to avoid incompatibilities in adult intensive care patients]

Publication Name: Medizinische Klinik, Intensivmedizin und Notfallmedizin

Publication Date: 2026-06

DOI: 10.1007/s00063-025-01396-0

Heparin

Publication Name: Reactions Weekly

Publication Date: 2026-02-21

DOI: 10.1007/s40278-026-92656-3

Heparin

Publication Name: Reactions Weekly

Publication Date: 2026-02-21

DOI: 10.1007/s40278-026-92655-3

The thrombelastometry parameter CTEXTEM as an independent risk factor for mortality in bleeding patients

Publication Name: European journal of trauma and emergency surgery : official publication of the European Trauma Society

Publication Date: 2026-02-16

DOI: 10.1007/s00068-025-03079-z

Circadian Rhythm and Efficacy of Argatroban in Ischemic Stroke with Alteplase: A Post Hoc Analysis of the ARAIS Trial

Publication Name: CNS Drugs

Publication Date: 2026-02-12

DOI: 10.1007/s40263-026-01270-3

Argatroban, 99%

Product Information

General Information

Safety Information

References Data Source From Pubchem

[Development of an infusion regimen to avoid incompatibilities in adult intensive care patients]

Heparin

Heparin

The thrombelastometry parameter CTEXTEM as an independent risk factor for mortality in bleeding patients

Circadian Rhythm and Efficacy of Argatroban in Ischemic Stroke with Alteplase: A Post Hoc Analysis of the ARAIS Trial

Argatroban, 99%

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-3-methoxy-L-phenylalanine

2-Ethynyl-1,3,5-trimethylbenzene, 97%

Tris-acetic acid electrophoresis buffer (50×TAE)

[S(R)]-N-[(1S)-1-[2-(Diadamantanphosphino)phenyl]ethyl]-N,2-dimethyl-2-propanesulfinamide, 95%

Mycophenolate Mofetil EP Impurity H

3-(4-Bromo-2-fluoro-3-methoxyphenyl)-3-oxo-propionic acid ethyl ester

Isochroman-1-carboxylic acid

Mycophenolate Mofetil

About Us

Popular Searches

Contact

#title#

Features
Availability:
Price
Options
Actions

Argatroban, 99%

Product Information

General Information

Safety Information

References Data Source From Pubchem

[Development of an infusion regimen to avoid incompatibilities in adult intensive care patients]

Heparin

Heparin

The thrombelastometry parameter CTEXTEM as an independent risk factor for mortality in bleeding patients

Circadian Rhythm and Efficacy of Argatroban in Ischemic Stroke with Alteplase: A Post Hoc Analysis of the ARAIS Trial

Argatroban, 99%

Related Product

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-3-methoxy-L-phenylalanine

2-Ethynyl-1,3,5-trimethylbenzene, 97%

Tris-acetic acid electrophoresis buffer (50×TAE)

[S(R)]-N-[(1S)-1-[2-(Diadamantanphosphino)phenyl]ethyl]-N,2-dimethyl-2-propanesulfinamide, 95%

Mycophenolate Mofetil EP Impurity H

3-(4-Bromo-2-fluoro-3-methoxyphenyl)-3-oxo-propionic acid ethyl ester

Isochroman-1-carboxylic acid

Mycophenolate Mofetil

#title#

Login

Register